文献速递免疫规划传染病防控与疫情报告

中国西南地区儿童肺炎链球菌分子特征及rPfbA蛋白疫苗评估

Molecular characterization of Streptococcus pneumoniae in children living in southwest China and assessment of a potential protein vaccine, rPfbA.
PubMed 文献 · Vaccine · 2019-01-02

本研究对中国西南地区儿童分离的肺炎链球菌进行分子特征分析,发现流行血清型以19F、19A、6B、14和23F为主,PCV13覆盖率高达93.3%,多数菌株对红霉素和克林霉素耐药。小鼠模型显示黏膜免疫rPfbA可诱导特异性抗体反应,减少肺和鼻咽部定植并抵抗攻击,建议该地区儿童接种PCV13。

要点

  • 西南地区儿童肺炎链球菌以19F、19A、6B、14和23F血清型为主,PCV13覆盖率93.3%。
  • 多数分离株对红霉素(95.1%)和克林霉素(90.2%)耐药。
  • rPfbA黏膜免疫在小鼠中诱导抗体反应,减少定植并提供攻击保护。

核心结论

  • 基于流行病学监测的疫苗策略可更适应特定地区并降低成本。
  • 建议目前居住在中国西南地区的儿童接种PCV13。

研究设计与样本

  • 对儿童分离的肺炎链球菌进行分子特征分析,包括血清型、毒力基因和菌毛分析。
  • 对7个管家基因测序以鉴定序列型(ST),并用微量肉汤稀释法分析抗生素耐药性。
  • 在小鼠肺炎链球菌感染模型中通过攻击和被动转移分析评估重组纤溶酶和纤连蛋白结合蛋白A(rPfbA)的保护效果,并评估免疫后细胞因子变化。

主要发现

  • 流行血清型为19F(31.4%)、19A(21.6%)、6B(13.7%)、14(11.8%)和23F(9.8%)。
  • PCV13在93.3%的分离株中覆盖率高。
  • 优势ST为ST271(23.5%)、ST320(21.6%)和ST876(11.8%)。
  • 多数分离株对红霉素(95.1%)和克林霉素(90.2%)耐药。
  • 高原和盆地地区分离株的分子分布和抗生素耐药率存在差异。

关键数值与推荐

  • 流行血清型:19F(31.4%)、19A(21.6%)、6B(13.7%)、14(11.8%)、23F(9.8%)。
  • PCV13覆盖率:93.3%的分离株。
  • 优势ST:ST271(23.5%)、ST320(21.6%)、ST876(11.8%)。
  • 耐药率:红霉素95.1%,克林霉素90.2%。
  • 毒力基因携带率:ply、cbpA、phtD和nanA超过93%;pilu-1、pilus-2和pfbA超过半数。

临床怎么用

  • 建议中国西南地区儿童接种PCV13以覆盖主要流行血清型。
  • rPfbA蛋白疫苗策略可能提供针对肺炎链球菌的保护,但需进一步临床研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few children living in southwest China are vaccinated against Streptococcus pneumoniae (S. pneumoniae), which is an important pathogen in causing high morbidity and high mortality. This study aimed the molecular characterization of S. pneumoniae strains isolated from children and a new vaccine strategy based on a potential protein antigen. METHODS: Molecular characterizations, including serotype, virulence gene and pilus analyses, were performed using PCR. Seven housekeeping genes were sequenced to identify the sequence types (STs), and antibiotic resistance was analysed using the microdilution broth method. In addition, we evaluated the protective effects of recombinant plasmin- and fibronectin-binding protein A (rPfbA) in murine pneumococcal infection models by challenge and passive transfer analyses, and assessed cytokine changes after immunization. RESULTS: The prevalent serotypes were 19F (31.4%), 19A (21.6%), 6B (13.7%), 14 (11.8%) and 23F (9.8%), and the coverage rates of the 13-valent pneumococcal conjugate vaccine (PCV13) were high in 93.3% of the isolates. The predominant STs were ST271 (23.5%), ST320 (21.6%) and ST876 (11.8%). Most of the S. pneumoniae isolates were resistant to erythromycin (95.1%) and clindamycin (90.2%). The molecular distributions and antibiotic resistance rates of the S. pneumoniae isolates differed between the plateau and the basin regions. More than 93% of the S. pneumoniae isolates carried ply, cbpA, phtD and nanA, and over half of the isolates carried pilus-1, pilus-2 and pfbA. Mucosal immunization with rPfbA induced pneumococcal specific antibody responses which provided to eliminate colonization in lung and nasopharynx, and protection against pneumococcal challenge. CONCLUSION: Vaccine strategies based on epidemiological surveillance can be more adaptive to specific areas, reduce costs and protect against changing antigenic sites. We advise that children currently living in southwest China be vaccinated with PCV13.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yan Z, Cui Y, Zhou W, et al. Molecular characterization of Streptococcus pneumoniae in children living in southwest China and assessment of a potential protein vaccine, rPfbA. Vaccine. 2019. PMID: 30611601. doi:10.1016/j.vaccine.2018.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。